EUVIMEDEUVIMED entdecken
Open Access

Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials

Xi Fang iD, Bingkai Wang, Guangyu Tong iD, Liangyuan Hu, Shuangge Ma iD, Fan Li iD

Statistics in Medicine · 2026-06 · 45 (13-14)

DOI: 10.1002/sim.70599 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, online erschienen am 26.05.2026. Verfasst von Xi Fang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Models, Statistical. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIA NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Progressive multi‐state survival outcomes are common in trials with recurrent or sequential events and require treatment effect estimands that remain interpretable without proportional intensity or Markov assumptions. The restricted mean time in favor of treatment (RMT‐IF) extends the restricted mean survival time to ordered multi‐state processes and provides such an interpretable estimand. However, existing RMT‐IF methods are nonparametric, assume covariate‐independent censoring for independent observations, and do not accommodate cluster‐randomized trials (CRTs), limiting both efficiency and applicability. We develop a class of doubly robust estimators for RMT‐IF under right censoring using an augmented inverse‐probability weighting framework that combines stage‐specific outcome regression with arm‐specific censoring models, yielding consistency when either nuisance model is correctly specified. We further extend the framework to CRTs by formalizing both cluster‐level and individual‐level average RMT‐IF estimands to address informative cluster size and by constructing corresponding doubly robust estimators that account for within‐cluster correlation. For inference, we employ model‐agnostic jackknife variance estimators in both individually randomized and cluster‐randomized settings. Extensive simulation studies demonstrate finite‐sample performance, and the methods are illustrated using two randomized trial examples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicModels, StatisticalHumansComputer SimulationCluster AnalysisSurvival AnalysisTime FactorsData Interpretation, Statistical

Stichwörter der Autor:innen

covariate adjustmentcovariate‐dependent censoringdoubly‐robust estimationestimandsmulti‐state survival outcomerestricted mean time in favor

Autor:innen und Institutionen

  • Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut, USA.
  • Center for Methods in Implementation and Prevention Science, Yale School of Public Health, New Haven, Connecticut, USA.
  • Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey, USA.

ORCID-Profile: Xi Fang, Guangyu Tong, Shuangge Ma, Fan Li

Förderung

  • NHLBI NIH HHS
  • NIA NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Fang, X., Wang, B., Tong, G., Hu, L., Ma, S., & Li, F. (2026). Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials. Statistics in Medicine, 45(13-14). https://doi.org/10.1002/sim.70599

Vancouver

Fang X, Wang B, Tong G, Hu L, Ma S, Li F. Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials. Statistics in Medicine. 2026;45(13-14). doi:10.1002/sim.70599

BibTeX
@article{Fang2026,
  author = {Fang, Xi and Wang, Bingkai and Tong, Guangyu and Hu, Liangyuan and Ma, Shuangge and Li, Fan},
  title = {Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual‐ and Cluster‐Randomized Trials},
  journal = {Statistics in Medicine},
  year = {2026},
  volume = {45},
  number = {13-14},
  doi = {10.1002/sim.70599}
}
Kostenlos starten →